2027 Southern Hemisphere Influenza Vaccine
Closed Solicitation Posted
- Solicitation number
- SPE2DP26R0002
- Agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Logistics Agency Troop Support Medical is soliciting proposals for Southern Hemisphere Influenza Vaccine for the 2027–2028 flu season, with proposals due October 14, 2026. The procurement is unrestricted; no set-aside applies.
Approximately 30,000 doses are required (quantities may increase or decrease pending final Service requirements). The vaccine shall be pre-measured 0.5 milliliters per dose, pre-filled in a commercially available syringe for intramuscular administration in healthy individuals aged 6 months and older. The product must be FDA-approved and CDC Advisory Committee on Immunization Practices (ACIP) recommended. The formula will be determined by the FDA's Vaccines and Related Biological Products Advisory Committee for the 2027–2028 season. All vaccines must be thimerosal and preservative-free with proper cold chain management, temperature monitoring devices (2°C to 8°C), and an 18-month minimum shelf life.
An indefinite delivery, indefinite quantity contract is proposed for a 12-month term. The guaranteed minimum is 75 percent of the annual estimate (2,250 packages); the maximum is 150 percent (4,500 packages). All deliveries must reach DLA Distribution Susquehanna in New Cumberland, Pennsylvania by March 31, 2027. The contractor must be capable of delivering 100 percent of requirements by March 12, 2027; alternative delivery schedules will be considered. Pricing is firm-fixed, F.O.B. destination, with a Federal Excise Tax of $7.50 per package assessed separately and excluded from the unit price. Non-manufacturers must submit a manufacturer commitment letter confirming uninterrupted supply and fixed pricing for contract life. The NAICS code is 325414, Biological Product (except Diagnostic) Manufacturing. Proposals must be submitted through the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil or SAM.gov. Contact Rosbert Jones (rosbert.jones@dla.mil) with questions.
Notice text
The Defense Logistics Agency Troop Support is soliciting for the supply of Southern Hemisphere Influenza Vaccine for the 2027-2028 flu season. Approximately 30,000 doses are included in this requirement. (Quantities may increase or decrease pending receipt of final Service requirements.) The vaccines shall be a pre-measured 0.5 ML dose, each dose shall be pre-filled in a commercially available syringe for intramuscular administration in healthy individuals aged 6 months and older. The vaccine shall be U.S. Food & Drug Administration (FDA)-approved and U.S. Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) recommended.
The formula for the 2027-2028 season vaccine shall be determined by the FDA’s Vaccines and Related Biological Products Advisory Committee. Other specification data is included in the solicitation. Successful contractor must have FDA Approval and the vaccine must be ACIP recommended. National Stock Numbers shall be established at time of award.
An indefinite quantity contract is proposed. The quantity indicated is an annual estimate only. (Quantities may increase or decrease pending receipt of final Service requirements.) The guaranteed minimum will be 75% of the annual estimate, and a contract maximum will be established at 150% of the annual estimate.
All quantities shall be delivered to the Defense Depot New Cumberland, PA. The contractor shall be capable of delivering 100% of the requirements by March 12, 2027. This delivery schedule is the preferred delivery schedule. Other delivery schedules will be considered.
A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and SAM.gov at https://www.sam.gov. Interested parties should contact Rosbert Jones (rosbert.jones@dla.mil) for any questions/comments. Interested parties are further advised to set up automated notifications of presolicitation or solicitation changes through this website. The current projected solicitation date is September 28, 2026, closing on Ocrtober 14, 2026. DLA reserves the right to issue the solicitation before or after the projected solicitation date.
Files
| File | Type | Posted |
|---|---|---|
| How_to_upload_Proposal_in_DIBBS.pdf | ||
| SF1449_SPE2DP26R0002.PDF |
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Solicitation | |
| 2027 Southern Hemisphere Influenza Vaccine | Pre-Solicitation | |
| 2027 Southern Hemisphere Influenza Vaccine | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response | Office of the Assistant Secretary for Preparedness and Response | No set-aside | |
| Epinephrine Injector | Medical Supply Chain | No set-aside | |
| Atropine Auto-Injector | Medical Supply Chain | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity